إعلان
إعلان
AYTU
AYTU BioPharma, Inc. Common Stock
2.69
USDبرعاية
-0.14
-4.95%
٠٨ يناير, ١٥:٥٨ UTC -5
مغلق
بعد الإغلاق
2.72
+0.03
+1.08%
تقارير أرباح AYTU
النسبة الإيجابية المفاجئة
AYTU تفوق 21 من 36 آخر التقديرات.
58%
التقرير التالي
بيانات التقرير القادم
١٠ فبراير ٢٠٢٦
Estimate for Q2 26 (Revenue/ EPS)
$12.42M
/-$0.61
التغير الضمني من Q1 26 (Revenue/ EPS)
-10.59%
/-390.48%
التغير الضمني من Q2 25 (Revenue/ EPS)
-23.45%
/+134.62%
AYTU BioPharma, Inc. Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, AYTU reported earnings of 0.21 USD per share (EPS) for Q1 26, beating the estimate of -0.23 USD, resulting in a 189.51% surprise. Revenue reached 13.89 مليون, compared to an expected 12.64 مليون, with a 9.83% difference. The market reacted with a +1.46% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 المحللين forecast an EPS of -0.61 USD, with revenue projected to reach 12.42 مليون USD, implying an نقصان of -390.48% EPS, and نقصان of -10.59% in Revenue from the last quarter.
الأسئلة الشائعة
What were AYTU BioPharma, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, AYTU BioPharma, Inc. Common Stock reported EPS of $0.21, beating estimates by 189.51%, and revenue of $13.89M, 9.83% above expectations.
How did the market react to AYTU BioPharma, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 1.46%, changed from $2.06 before the earnings release to $2.09 the day after.
When is AYTU BioPharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٠ فبراير ٢٠٢٦.
What are the forecasts for AYTU BioPharma, Inc. Common Stock's next earnings report?
Based on 5
المحللين, AYTU BioPharma, Inc. Common Stock is expected to report EPS of -$0.61 and revenue of $12.42M for Q2 2026.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان